Myriad Genetics buy Piper Sandler
Start price
15.05.25
/
50%
€3.68
Target price
15.05.26
€8.04
Performance (%)
22.83%
Price
23.02.26
€3.68
Summary
This prediction is currently active. The prediction currently has a performance of 22.83%. This prediction currently runs until 15.05.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -4.813% | -4.813% |
| iShares Core DAX® | 0,61 % | 0,34 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % |
| iShares S&P 500 | 0,54 % | -0,70 % |
Comments by Piper_Sandler for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at Piper Sandler from $12.50 to $9.00. They now have an "overweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat